Dr SELMANI Zohair

Fiche personne

Coordonnées

Hôpital Jean Minjoz
3 boulevard Fleming
25030 BESANCON Cedex

03 70 63 20 54

Territoire

Franche-Comté

Statut

Hospitalo-Universitaire

Affiliation

Centre hospitalier régional universitaire de Besançon (CHRU Besançon)

Université de Franche-Comté (UFC)

Équipes/plateformes

Plateforme EPIGENExp

Projets

Identification de profil de méthylation spécifiques de lésions précancéreuses coliques détectable par PCR digitale sur ADN circulant tumoral (IMPACT)

2021 - Porteur du projet : Dr PEIXOTO Paul - Partenaire : Pr BORG Christophe , Dr SELMANI Zohair

Publications

COL25A1 and METAP1D DNA methylation are promising liquid biopsy epigenetic biomarkers of colorectal cancer using digital PCR.

Overs A, Peixoto P, Hervouet E, Molimard C, Monnien F, Durand J, Guittaut M, Vienot A, Viot J, Herfs M, Borg C, Feugeas JP, Selmani Z

Clin Epigenetics. 2024 10 18;16(1):146

Temporal and spatial heterogeneity of HER2 status in metastatic colorectal cancer.

D'Angelo F, Monnien F, Overs A, Pem I, Dor F, Abad M, Felix S, Selmani Z, Lakkis Z, Borg C, Doussot A, Bibeau F, Molimard C

Diagn Pathol. 2024 06 22;19(1):88

Prognostic Factors for Long-Term Eribulin Response in a Cohort of Patients With HER2-Negative Metastatic Breast Cancer.

El Kaddissi A, Vernerey D, Falcoz A, Mansi L, Bazan F, Chaigneau L, Dobi E, Goujon M, Meneveau N, Paillard MJ, Selmani Z, Viot J, Molimard C, Monnien F, Woronoff AS, Curtit E, Borg C, Meynard G

Clin Breast Cancer. 2024 06 19;:

The "extreme phenotype approach" applied to male breast cancer allows the identification of rare variants of ATR as potential breast cancer susceptibility alleles.

Chevarin M, Alcantara D, Albuisson J, Collonge-Rame MA, Populaire C, Selmani Z, Baurand A, Sawka C, Bertolone G, Callier P, Duffourd Y, Jonveaux P, Bignon YJ, Coupier I, Cornelis F, Cordier C, Mozelle-Nivoix M, Rivière JB, Kuentz P, Thauvin C, Boidot R, Ghiringhelli F, O'Driscoll M, Faivre L, Nambot S

Oncotarget. 2023 02 7;14:111-125

Low correlation between Ki67 assessed by qRT-PCR in Oncotype Dx score and Ki67 assessed by Immunohistochemistry.

Selmani Z, Molimard C, Overs A, Bazan F, Chaigneau L, Dobi E, Meneveau N, Mansi L, Paillard MJ, Meynard G, Viot J, Algros MP, Borg C, Feugeas JP, Pivot X, Prétet JL, Curtit E

Sci Rep. 2022 Mar 7;12(1):3617

The detection of specific hypermethylated WIF1 and NPY genes in circulating DNA by crystal digital PCR™ is a powerful new tool for colorectal cancer diagnosis and screening.

Overs A, Flammang M, Hervouet E, Bermont L, Pretet JL, Christophe B, Selmani Z

BMC Cancer. 2021 Oct 10;21(1):1092

HPV16 Load Is a Potential Biomarker to Predict Risk of High-Grade Cervical Lesions in High-Risk HPV-Infected Women: A Large Longitudinal French Hospital-Based Cohort Study.

Baumann A, Henriques J, Selmani Z, Meurisse A, Lepiller Q, Vernerey D, Valmary-Degano S, Paget-Bailly S, Riethmuller D, Ramanah R, Mougin C, Prétet JL

Cancers (Basel). 2021 Aug 18;13(16):

FGFR alterations in urothelial carcinoma: Picking the right target.

Hubert P, Selmani Z, Loriot Y, Thiery-Vuillemin A

Bull Cancer. 2021 May 17;:

[Vaccination against papillomavirus : arguments and evidence of effectiveness].

Prétet JL, Selmani Z, Mougin C, Pepin-Puget L, Lepiller Q

Rev Prat. 2020 Jan;70(1):99-103

Enterocolitis in Patients with Cancer Treated with Docetaxel.

Fiteni F, Paillard MJ, Orillard E, Lefebvre L, Nadjafizadeh S, Selmani Z, Benhamida S, Roland A, Baumann A, Vienot A, Houédé N, Pivot X

Anticancer Res.. 2018 04;38(4):2443-2446

Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells.

Selmani Z, Naji A, Zidi I, Favier B, Gaiffe E, Obert L, Borg C, Saas P, Tiberghien P, Rouas-Freiss N, Carosella ED, Deschaseaux F

Stem Cells. 2008 Jan;26(1):212-22

Two types of circulating endothelial progenitor cells in patients receiving long term therapy by HMG-CoA reductase inhibitors.

Deschaseaux F, Selmani Z, Falcoz PE, Mersin N, Meneveau N, Penfornis A, Kleinclauss C, Chocron S, Etievent JP, Tiberghien P, Kantelip JP, Davani S

Eur J Pharmacol. 2007 May 7;562(1-2):111-8

Human and rodent bone marrow mesenchymal stem cells that express primitive stem cell markers can be directly enriched by using the CD49a molecule.

Gindraux F, Selmani Z, Obert L, Davani S, Tiberghien P, Hervé P, Deschaseaux F

Cell Tissue Res. 2007 Mar;327(3):471-83

Voir plus

Fiche personne Projets Publications

Retrouvez aussi

Unités de recherche, établissements

Projets de recherche

Publications scientifiques